abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2011年6月1日

著者:
Lundbeck

Lundbeck's position regarding the misuse of pentobarbital in execution of prisoners

全てのタグを見る
Lundbeck is dedicated to saving people’s lives. Use of our products to end lives contradicts everything we’re in business to do. Lundbeck is opposed to the use of its product for the purpose of capital punishment. Lundbeck markets pentobarbital solely for its approved use, among other things to treat serious conditions such as a severe and life threatening emergency epilepsy...The use of this product to carry out the death penalty in US prisons falls outside its approved indications...Lundbeck does not promote pentobarbital for use in lethal injections or any other unapproved use...Based on our evaluation and the advice of external experts, we have concluded that there are no viable steps Lundbeck can take to prevent end-users from obtaining the product for unapproved use, short of withdrawing the product from the market.